Release Date: 25/05/16 11:23 Summary: Appendix 4D and Half Year Financial Report-HSK.AX Price Sensitive: Yes Download Document 594.97KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status